Pamlico BioPharma's Series A Round

Pamlico BioPharma raised a round of funding on April 29, 2015.

Pamlico BioPharma develops fully-human monoclonal antibody (hmAb) therapeutics for the rapid diagnosis and treatment of infectious diseases and cancer. Pamlico isolated antibodies to all 24 vaccine se…

Articles about Pamlico BioPharma's Series A Round: